Effects of sildenafil and vardenafil on erectile dysfunction and healthrelated quality of life in haemodialysis patients: A prospective randomized crossover study

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3729-3733

  Turk, Suleyman ^a   Solak, Yalcin ^a   Kan, Seyfullah ^a   Atalay, Huseyin ^a   Kilinc, Mehmet ^a   Agca, Erhan ^b   Bodur, Said ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b Numune State Hospital   (Turkey)

Author keywords

Erectile dysfunction; Haemodialysis; Health related quality of life; Sildenafil; Vardenafil

Indexed keywords

SILDENAFIL; VARDENAFIL; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE;

ADULT; AGED; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ERECTILE DYSFUNCTION; FEMALE; FLUSHING; HEMODIALYSIS PATIENT; HUMAN; IMPOTENCE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SHORT FORM 36; SIDE EFFECT; TREATMENT DURATION; ARTICLE; CLINICAL TRIAL; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CROSS-OVER STUDIES; ERECTILE DYSFUNCTION; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; QUALITY OF LIFE; RENAL DIALYSIS; SULFONES; TRIAZINES; YOUNG ADULT;

EID: 78649425558     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq243     Document Type: Review

References (27)

1. Turk S, Karalezli G, Tonbul HZ et al. Erectile dysfunction and the effects of sildenafil treatment in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 1818-1822 (Pubitemid 32825447)
2. Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10: 1381-1388 (Pubitemid 29247005)
3. Turk S, Guney I, Altintepe L et al. Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract 2004; 96: C21-c27 (Pubitemid 38456617)
4. Turk S, Atalay H, Altintepe L et al. Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol 2006; 65: 113-118 (Pubitemid 43224484)
5. Goldstein I, Lue TF, Padma-Nathan H et al. For the Sildenafil Study Group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 38: 1397-1404 (Pubitemid 28221980)
6. Sahin Y, Aygün C, Peskircioglu CL et al. Efficacy and safety of sildenafil citrate in hemodialysis patients. Transplant Proc 2004; 36: 56-58 (Pubitemid 38177188)
7. Haning H, Niewohner U, Schenke T et al. Imidazo[5, 1-f][1, 2, 4]triazin- 4(3H)-ones, a new class of potent PDE 5 inhibitors. Bioorg Med Chem Lett 2002; 12: 865-868 (Pubitemid 34214962)
8. Crowe SM, Streetman DS. Vardenafil treatment for erectile dysfunction. Ann Pharmacother 2004; 38: 77-85 (Pubitemid 38018012)
9. Giuliano F, Peña BM, Mishra A et al. Efficacy results and quality-oflife measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res 2001; 10: 359-369 (Pubitemid 33079014)
10. Fisher WA, Rosen RC, Mollen M et al. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699-708 (Pubitemid 41742930)
11. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307-319 (Pubitemid 41025762)
12. McHorney CA, Ware JE Jr, Lu JF et al. The MOS 36-Item Short- Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66
13. Koçyigit H, Aydemir Ölmez N et al. Kisa form-36 (SF-36)'nin Türkçe versiyonunun güvenirligi ve geçerliligi. Ilaçve Tedavi Dergisi 1999; 12: 102-106
14. Lew-Starowicz M, Gellert R. The sexuality and quality of life of hemodialyzed patients-ASED multicenter study. J Sex Med 2009; 6: 1062-1071
15. Mittal SK, Ahern L, Flaster E et al. Self-Assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1387-1394 (Pubitemid 32640593)
16. Lopes AA, Bragg-Gresham JL, Satayathum S et al. Worldwide Dialysis Outcomes and Practice Patterns Study Committee. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2003; 41: 605-615 (Pubitemid 36278378)
17. Mapes DL, Lopes AA, Satayathum S et al. Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339-349 (Pubitemid 36714189)
18. Rosas SE, Joffe M, Franklin E et al. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int 2003; 64: 232-238 (Pubitemid 36714176)
19. Doggrell S. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? Int J Impot Res 2007; 19: 281-295 (Pubitemid 46701455)
20. Guay AT, Perez JB, Jacobson J et al. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001; 22: 793-797 (Pubitemid 32781267)
21. Yeniçerioglu Y, Kefi A, Aslan G et al. Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis. BJU Int 2002; 90: 442-445 (Pubitemid 36124780)
22. Chen J, Mabjeesh NJ, Greenstein A et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol 2001; 165: 819-821 (Pubitemid 32156286)
23. McMahon CG. High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction. Int J Impot Res 2002; 14: 533-538 (Pubitemid 36068434)
24. Moore RA, Derry S, McQuay HJ. Indirect comparison of interventions using published randomised trials: Systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urol 2005; 5: 18
25. Carson CC, Hatzichristou DG, Carrier S et al. Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group. Erectile response with vardenafil in sildenafil nonresponders: A multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. BJU Int 2004; 94: 1301-1309
26. Morales A, Gingell C, Collins M et al. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69-73
27. Porst H, Rosen R, Padma-Nathan H et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial. Int J Impot Res 2001; 13: 192-199 (Pubitemid 32743600)